Happy Friday all!
Its a weekend of camping in Gippsland for us…
Excited to get back with nature!
Across Markets…
This Afternoon, the Australian sharemarket notched up its biggest two-week gain since early June as the index climbed 3.5 per cent over the week as vaccine hopes triggered a rotation away from virus winners.
The S&P/ASX200 Index fell 13 points, or 0.2 per cent, to 6405.2 points on Friday as Wall Street retreated on growing concerns about the number of rising new COVID-19 cases and the prospect of more lockdowns.
But the benchmark’s gain for the week brought its advance to 8 per cent over the past two weeks – the strongest two week run since the weeks ended May 29 and June 5.
BHP (down 1.9 per cent), Transurban (down 0.9 per cent) and Wesfarmers (down 0.5 per cent) were the main drags on the market.
Gold stocks were a standout on Friday as the Australian dollar price for the precious metal rose above $2600 an ounce. Northern Star added 7.2 per cent and Newcrest Mining added 2.8 per cent.
Source: AFR
Lifespot Health (ASX: LSH) is further enhancing its leadership team and topping up cash reserves as it advances the development of its medical cannabis inhaler device program it claims will “significantly evolve the treatment options for patients both in Australia and overseas”.
Investors are also seeing the value as Lifespot Health leads the way in the inhaled Medical Cannabis market, developing a solid clinical trial program to establish the clinical safety and pharmacokinetics of its inhaler devices, with medical cannabis company Cannvalate Pty Ltd and investment group MDI Wealth Pty Ltd recently joining the LifeSpot Health family.
Speaking with Small Caps, Lifespot chief executive officer Matthew Golden described the standout features of Lifespot’s technology that gave Cannvalate and MDI Wealth the confidence to invest.
“Lifespot has viewed cannabis as a medical solution for patients from its inception, and it’s backed that position with the development of its inhaler devices to meet the needs of patient and physicians. It’s a position that aligns not only with medical professionals but also knowledgeable investors such as Cannvalate and MDI.”
Source: Small Caps
Across Asia, China and Hong Kong stocks fell on Friday following the Trump administration’s decision to ban U.S. investments in firms linked to the Chinese military, with sentiment also hurt by more bond defaults.
The CSI300 index fell 1.0% to 4,862.01 at the end of the morning session, while the Shanghai Composite Index lost 0.8%, to 3,313.75.
For the week, CSI300 shed 0.5%, while SSEC was flat.
U.S. President Donald Trump’s administration unveiled an executive order prohibiting U.S. investments in Chinese firms that Washington says are owned or controlled by the Chinese military.
The move seeks to deter U.S. investment firms, pension funds and others from buying shares of 31 Chinese companies that were designated by the Defense Department as backed by the Chinese military.
Source: Reuters
Sector: Consumer Discretionary
Year: 2019
Deal Type: Placement
Raise Amount: $2.2m
Price Change: $0.048 +2.13%
Sector: Consumer Discretionary
Year: 2018, 2019
Deal Type: Seed, Bridging and IPO
Raise Amount: $10m
Price Change: $0.12 Unchanged
Sector: Technology
Year: 2018
Deal Type: Seed and IPO
Raise Amount: $10m
Price Change: $0.077 +1.32%
Sector: Mining
Year: 2017
Deal Type: Seed & IPO
Raise Amount: $5m
Price Change: $0.20 Unchanged
Sector: Mining
Year: 2017
Deal Type: IPO & Placement
Raise Amount: $6m
Price Change: $0.058 -1.69%
Sector: Healthcare Equipment and Services
Year: 2016
Deal Type: IPO
Raise Amount: $8m
Price Change: $0.080 +9.59%
Sector: Materials
Year: 2016
Deal Type: IPO
Raise Amount: $9m
Price Change: $0.026 Unchanged
Sector: Biotechnology
Year: 2015, 2017, 2018
Deal Type: Placements & IPO
Raise Amount: $5m
Price Change: $3.05 +1.67%
Sector: Media an Entertainment
Year: 2016
Deal Type: Reverse Takeover
Raise Amount: $4m
Price Change: $0.043 Unchanged
Sector: mining
Year: 2018, 2019, 2020
Deal Type: Placements & Rights Offer
Raise Amount: $1.5m
Price Change: $0.0090 Unchanged
Sector: Discretionary
Year: 2020
Deal Type: Placement
Raise Amount: $1.3M
Price Change: $0.0050 Unchanged
Sector: Hemp & CBD
Year: 2020
Deal Type: Pre IPO
Raise Amount: $2.5m
Sector: Psychedelic assisted Therapy
Year: 2020
Deal Type: Pre IPO
Raise Amount: $1.5m
Price Change: CAD $0.055 -8.33%
Sector: Mining
Year: 2020
Deal Type: Placement
Raise Amount: $333k
Sector: Gaming & Digital Advertising
Year: 2020
Deal Type: Placement
Raise Amount: $1.25m
Sector: Mining (Gold)
Year: 2020
Deal Type: Placement
Raise Amount: $982k
Price Change: $0.012 +20.00%
Sector: Mining (Gold/Silver)
Year: 2020
Deal Type: Placement
Raise Amount: $2.3m
Price Change: $0.014 Unchanged
If you would like more information on future Peak deals, please don’t hesitate to get in touch.
Peak accepts no responsibility for any views expressed and marketing material contained in this email except where the message specifically states otherwise and the sender is authorised to state them to be the views of Peak. Information provided in this email is general advise only and does take account your objectives, financial situation or needs. Before acting on any advice in this email, Peak recommends that you consider whether it is appropriate for your circumstances. If this email contains reference to any financial products, you should obtain the current Product Disclosure Statement (PDS) or other disclosure documents for the particular products and consider this information before making any decisions regarding the products. The Financial Services Guide (FSG) can be found at www.peakassetmanagement.com.au or by telephoning Peak on 1300 304 460
